The SCAN Family: Characterization of ZNF174
SCAN 系列:ZNF174 的表征
基本信息
- 批准号:6640604
- 负责人:
- 金额:$ 23.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-01-01 至 2005-12-31
- 项目状态:已结题
- 来源:
- 关键词:DNA binding protein antibody binding sites cell differentiation complementary DNA dimer gel mobility shift assay gene expression gene induction /repression genetic regulation genetic regulatory element liquid chromatography mass spectrometry molecular cloning platelet derived growth factor polymerase chain reaction protein localization protein protein interaction protein sequence protein structure function tissue /cell culture transcription factor yeast two hybrid system
项目摘要
DESCRIPTION (provided by applicant): In a search for negative regulators of
growth factor gene expression, our group cloned a new zinc finger transcription
factor, which was designated ZNFI74. Analysis of the open reading frame
revealed two types of conserved elements. The first of these structures were
three consensus Cys2-His2 (C2H2) type zinc fingers, while the second was a
novel extended motif which we designated the SCAN domain. The SCAN domain is a
highly conserved 80 amino acid modular element that is found in a family of
more than 50 human Cys2-His2 (C2H2) zinc finger proteins. Like the leucine
zipper, the SCAN domain appears to control association of SCAN domain
containing proteins into non-covalent, multisubunit complexes and may be the
primary mechanism underlying partner choice in the oligomenzation of these
zinc-finger transcription factors. An attractive possibility is that the domain
generates combinatorial diversity within the SCAN family of proteins.
Heterodimer formation could lead to novel DNA recognition properties or to
different regulatory activities, thus expanding the repertoire of the family.
Only a few of the SCAN family members have been characterized, but the initial
findings suggest that these genes play roles in development and
differentiation. Despite the number of members in this family, remarkably
little is known about the domain itself or the functions of most of the
proteins defined by the domain. To investigate this family, we propose three
specific aims to define ZNF174 and characterize the SCAN domain. Specific Aim
1: To further characterize ZNF174, a founding member of the SCAN family;
Specific Aim 2: To determine the proteins that interact with the ZNF174 SCAN
domain; Specific Aim 3: To further characterize the ability of the ZNF 174 SCAN
domain to inhibit DNA binding. Collectively, these studies should define this
transcription factor and provide mechanistic insights into the large number of
C2H2 type zinc finger proteins defined by the SCAN domain.
描述(由申请人提供):在搜索负向调节器时
生长因子基因的表达,本课题组克隆了一个新的锌指转录
因子,命名为ZNFI74。试析开放阅读框架
揭示了两种类型的守恒元。第一个这样的结构是
三种常见的Cys2-His2(C2H2)型锌指,而第二种是
新的扩展基序,我们将其命名为扫描结构域。扫描域是一种
高度保守的80个氨基酸的模块化元件,存在于一个
超过50个人类Cys2-His2(C2H2)锌指蛋白。像亮氨酸一样
拉链,扫描域似乎控制着扫描域的关联
含有蛋白质的非共价多亚单位复合体,可能是
在这些稀有化中潜在的合作伙伴选择的主要机制
锌指转录因子。一个有吸引力的可能性是,该领域
在扫描蛋白质家族中产生组合多样性。
异源二聚体的形成可能导致新的DNA识别特性或
不同的监管活动,从而扩大了家庭的曲目。
只有几个扫描家族成员被描述了特征,但最初的
研究结果表明,这些基因在发育和
差异化。尽管这个家庭的成员数量很多,但值得注意的是
对于域本身或大多数
由结构域定义的蛋白质。为了调查这个家庭,我们提出了三个
特定的目的是定义ZNF174并表征扫描结构域。特定目标
1:进一步描述扫描家族的创始成员ZNF174;
特定目标2:确定与ZNF174扫描相互作用的蛋白质
领域;具体目标3:进一步表征ZNF 174扫描的能力
结构域来抑制DNA结合。总的来说,这些研究应该界定这一点
转录因子,并提供对大量
由Scan结构域定义的C2H2型锌指蛋白。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tucker O Collins其他文献
Tucker O Collins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tucker O Collins', 18)}}的其他基金
NUCLEAR FACTOR KAPPA BETA AND INITIATION OF THE ATHEROSC
核因子 KAPPA Beta 和动脉粥样硬化的引发
- 批准号:
7056678 - 财政年份:2005
- 资助金额:
$ 23.23万 - 项目类别:
Pathobiology of the Developing Cardiovascular System
心血管系统发育的病理学
- 批准号:
7084550 - 财政年份:2005
- 资助金额:
$ 23.23万 - 项目类别:
Pathobiology of the Developing Cardiovascular System
心血管系统发育的病理学
- 批准号:
6845019 - 财政年份:2005
- 资助金额:
$ 23.23万 - 项目类别:
The SCAN Family: Characterization of ZNF174
SCAN 系列:ZNF174 的表征
- 批准号:
6689558 - 财政年份:2002
- 资助金额:
$ 23.23万 - 项目类别:
The SCAN Family: Characterization of ZNF174
SCAN 系列:ZNF174 的表征
- 批准号:
6552994 - 财政年份:2002
- 资助金额:
$ 23.23万 - 项目类别:
The SCAN Family: Characterization of ZNF174
SCAN 系列:ZNF174 的表征
- 批准号:
6836081 - 财政年份:2002
- 资助金额:
$ 23.23万 - 项目类别:
NUCLEAR FACTOR KAPPA BETA AND THE INITIATION OF THE ATHEROSCLEROTIC LESION
核因子 Kappa Beta 与动脉粥样硬化病变的发生
- 批准号:
6477453 - 财政年份:2001
- 资助金额:
$ 23.23万 - 项目类别:
相似海外基金
Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
- 批准号:
502607 - 财政年份:2024
- 资助金额:
$ 23.23万 - 项目类别:
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
- 批准号:
EP/Y024540/1 - 财政年份:2024
- 资助金额:
$ 23.23万 - 项目类别:
Fellowship
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
- 批准号:
MR/Y008847/1 - 财政年份:2024
- 资助金额:
$ 23.23万 - 项目类别:
Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
- 批准号:
BB/Y002180/1 - 财政年份:2024
- 资助金额:
$ 23.23万 - 项目类别:
Research Grant
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
- 批准号:
502578 - 财政年份:2024
- 资助金额:
$ 23.23万 - 项目类别:
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 23.23万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
- 批准号:
MR/Y003616/1 - 财政年份:2024
- 资助金额:
$ 23.23万 - 项目类别:
Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
- 批准号:
MR/Y033698/1 - 财政年份:2024
- 资助金额:
$ 23.23万 - 项目类别:
Research Grant
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
- 批准号:
23H03716 - 财政年份:2023
- 资助金额:
$ 23.23万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis research of anti-Sez6l2 antibody associated encephalopathy
抗Sez6l2抗体相关脑病的分析研究
- 批准号:
23K06940 - 财政年份:2023
- 资助金额:
$ 23.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




